News Sentiment

AYTU sentiment intelligence

Aytu BioScience Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 10 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 2.25 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 10

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+4.2% over one week, +4.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Aytu BioPharma, Inc. Actuals & Estimates (NASDAQ:AYTU)

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 4.2% Price confirming higher
Trend fit Trend inactive 4.7% over four weeks
Fair value -1.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 8
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 10
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 3
simplywall.st 3
PR Newswire 2
Market source 1
Issuewire 1

Event Lens

What the news is about

Classified themes
Market update 6
Earnings 3
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-10 of 10
TradingView Direct company coverage

Aytu BioPharma, Inc. Actuals & Estimates (NASDAQ:AYTU)

This article provides an overview of Aytu BioPharma, Inc. (NASDAQ: AYTU) financial actuals and estimates, including its stock price performance, analyst forecasts, and historical price data. It also details the company's financial statements, upcoming earnings reports, revenue, n

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 13:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Aytu BioPharma, Inc. – NASDAQ:AYTU

This article provides a brief overview of Aytu BioPharma, Inc. (NASDAQ:AYTU) focusing on its enterprise value to revenue forward metric. It's presented within the context of TradingView's financial data and market analysis platform. The content primarily serves as a placeholder o

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 09:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Aytu BioPharma, Inc. – NASDAQ:AYTU

This article provides access to the "Price to sales forward" metric for Aytu BioPharma, Inc. (NASDAQ: AYTU) on the TradingView platform. It navigates through the financial overview section for the company, indicating the market status and offering various financial and community

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 14:10
Source
TradingView